The injection of a mixture of ethanolamine oleate and thrombin as an effective treatment for bleeding duodenal ulcer was evaluated in 38 patients entered in a randomised prospective controlled trial. After a one week observation period, 1/19 (5.3%) treated patients and 11/19 (57.9%) control patients had suffered further bleeding (p<0005; CI=22%-74%). Emergency surgery was required in 1/19 in the treated group compared with 8/19 in the untreated group (CI=13%-61%; p<O0O5). The mean (SD) transfusion requirement in the treated group was 1*9 (0.5) U blood compared with 5*3 (0.7) U in the control group. No significant differences related to mortality were detected. In conclusion, local injection therapy is an effective means ofhaemostasis in patients with bleeding duodenal ulcer who are at risk of further bleeding.
Dr Manuel Moret6, Lertegui 14, Bajo C, 48930-Getxo (Vizcaya), Spain. Accepted for publication 1 July 1991 Although endoscopy mediated procedures based on thermal therapy (mono-or bipolar electrocoagulation, laser therapy, heater probe) have been considered as successful tools in haemostasis,' technical difficulties have considerably limited their use. Endoscopic haemostasis by means of monopolar electrocoagulation has been shown to be effective but it is a particularly difficult procedure to undertake in the duodenal cap. In a clinical trial,2 we were obliged to restrict its use to bleeding gastric ulcer patients. Thus, an altemative endoscopic method for treating duodenal bleeding was required.
Thrombin has been used either topically as a spray3 or injected locally,4 with seemingly good results. Local injection of several other substances -adrenalin,5 polidocanol,' absolute ethanol7 -has proved to be as effective in immediate haemostasis in several uncontrolled trials, but controlled trials have been few,89 albeit hopeful.
Comparative studies of different injected substances for bleeding peptic ulcers are lacking, so selection depends greatly on subjective views and partly reflects experience with variceal sclerotherapy. Ethanolamine oleate has been extensively used in variceal sclerosis, mainly in Commonwealth countries. However, we 
EXCLUSIONS
Five patients who seemed to meet the inclusion criteria were excluded before randomisation because excessive blood collection in the duodenum or duodenal deformity, or both, made treatment highly problematic and unsafe for technical reasons. One of them had alcoholic cirrhosis of the liver with suspected untreated hepatocellular carcinoma. Another patient presented in severe respiratory failure and had a pacemaker. (Exceptionally, he was given thrombosclerosis treatment, out of protocol, in very difficult conditions). Both these patients continued to bleed and died a few days later. Two patients had to be operated on because of persistent haemorrhage. The remaining patient followed an uneventful course, and bleeding stopped spontaneously.
Another patient who presented had suffered a cerebral stroke which made him highly uncollaborative. He was excluded from the study and followed an uneventful course.
MONITORING
An elementary questionnaire, with registration of basic haemodynamic data, was routinely completed at our unit before the endoscopic procedure was carried out. After endoscopy a form was filled in, including clinical and endoscopic data. Both groups of patients were treated by gastroenterologists not related to the trial, who were unaware of the applied therapy. They were only informed about the haemorrhagic activity at the end of the endoscopic procedure. Routine medical treatment included standard doses of H2 antagonists (cimetidine and ranitidine).
Evaluation of the effectiveness of treatment was undertaken over a seven day period and included the following: rebleeding, need for emergency surgery, and transfusion requirements. Rebleeding was defined as an episode of haematemesis or melaena, or both, with signs of shock or confirmative upper endoscopy, or both. Emergency surgery was defined as surgery carried out during the observation period. Transfusion requirements were measured separately for pre-and postendoscopy periods.
To determine whether there was any worsening ofthe ulcer secondary to sclerosant treatment, a control upper endoscopy was routinely undertaken at the end of the evaluation period in patients treated with thrombosclerosis. Discussion Mortality secondary to a bleeding duodenal ulcer is considered to be around 12%. About 30% of these patients will need some 5 U of blood during their hospital stay. When emergency surgery is indicated, mortality increases threefold in respect of patients who are not operated on,'8 and this justifies the search for a therapeutic endoscopic procedure to meet these patients' needs.
Our results suggest that thrombosclerosis is effective as emergency treatment for duodenal bleeding ulcer in patients selected according to the criteria we have outlined. We did not take into account the later clinical course of these patients because several subsequent treatments were prescribed, including surgery, which would have introduced bias to our analysis.
The effectiveness of local injection of a peptic bleeding ulcer is generally accepted, but there is no agreement over the proposed mechanism of its action. Some variables, such as ulcer size and site, have been proposed as influencing the effectiveness of the procedure.'9 Some authors have suggested that this treatment works through the compressive action of fluid deposits around bleeding vessel,4 while others state that action on vascular endothelium with subsequent thrombosis and necrosis are the natural haemostatic course. 'I The diversity of injected agents adds to the confusion over the therapeutic mechanism of local injection, particularly since studies comparing administered substances are lacking. In some studies patients were treated with adrenaline,5 with apparently good results, despite the lack of any known inflammatory or coagulative action of this substance on bleeding vessels.'320 In others a mixture of adrenaline and hypertonic saline,2' adrenaline and polidocanol,7922 or isolated polidocanol were used.4 Absolute ethanol is becoming one of the most common agents, with an apparent success rate of more than 90%.23 Some authors have added local injection to other haemostatic methods such as laser2425 or monopolar electrocoagulation.2' According to a study on the course of ulcer bleeding,27 a transverse vessel should be found at the ulcer base showing arteritis and pseudoaneurysmatic changes. It has been suggested that ethanol and sodium tetradecyl sulphate act by inflammatory mediated protracted coagulation,20 but this does seem to be the most likely explanation of the haemostatic effect. Added thrombin could potentiate the haemostatic effect of inflammatory substances. In considering the effect of adrenaline in haemostasis, the facts that spontaneous haemostasis occurs with a variable frequency in all series dealing with a bleeding peptic ulcer and visible vessel, including our own experience,2 and that adrenaline plus polidocanol are more effective than adrenaline alone28 should be taken into account. It is hard to believe that simple transitory vasoconstrictive agents or mechanical compression could, by themselves, achieve definitive haemostasis when severe disruption of the vessel integrity has occurred.
The requirement for blood transfusion as one of our inclusion criteria is based on reported data according to which transfused blood is directly related to emergency surgery needs. 18 Finally, poor visibility frequently hindered the treatment, as has also been pointed out by others. 9 Studies on bolus administration of vasoactive drugs may be indicated to circumvent this problem by momentarily lessening the blood flow, in spite of the current poor acceptance of these substances as definitive treatment for gastrointestinal bleeding.
In conclusion, thrombosclerosis does seem to be a useful tool in managing a bleeding duodenal ulcer in selected patients. 
